Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 28.48 |
| Open | 32.50 |
| Bid | 29.00 x 800 |
| Ask | 37.00 x 800 |
| Day's range | 30.24 - 35.79 |
| 52-week range | 15.58 - 78.58 |
| Volume | |
| Avg. volume | 319,564 |
| Market cap | 804.634M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Castle Biosciences Reports Second Quarter 2022 Results
FRIENDSWOOD, Texas, August 08, 2022--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the second quarter and six months ended June 30, 2022.
- Business Wire
American Gastroenterological Association (AGA) Clinical Practice Update States That TissueCypher® May Be Beneficial for Risk-Stratification of Patients with Non-Dysplastic Barrett’s Esophagus
FRIENDSWOOD, Texas, August 04, 2022--Castle announced that the AGA published an update article stating that TissueCypher® may be beneficial for risk-stratification of patients with NDBE.
- Business Wire
Castle Biosciences to Present at the Canaccord Genuity 42nd Annual Growth Conference
FRIENDSWOOD, Texas, August 03, 2022--Castle will present a company overview at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, Aug. 10, 2022, at 1:00 p.m. Eastern time
© 2022 Yahoo. All rights reserved.
